Additionally, S100B interacting proteins, such as ICACYBP, HMGB1, and S100A8, have been reported to positively correlate with the response of immunotherapy in HCC (Peng et al., 2021; Li et al., 2021). This evidence concerns the gene HMGB1 and hepatocellular carcinoma.